News and events / PARTPROBE together with the "Takeda Russia" will raise the issue of accessibility of drugs for patients with high-cost diseases

PARTPROBE together with the "Takeda Russia" will raise the issue of accessibility of drugs for patients with high-cost diseases


Takeda will support the II all-Russian pharmaceutical Race and will be the bronze partner of the event. As part of the large – scale event, leading industry experts-representatives of business, medical and scientific communities, patient and other public organizations-will join together to discuss the most relevant topics of Russian healthcare. Safety in healthcare, ensuring the quality and availability of medicines, and digital transformation of the industry are just some of the issues that experts will discuss.

The event will also include an open scientific and practical meeting on the topic "Improving the availability of medicines for acute patients" (on the example of oncogematological and hematological drugs). The purpose of the open meeting is to identify the most effective mechanisms of drug provision for acute patients on the example of hematological and hematological diseases, to form a unified approach to the treatment of hemoblastoses, to review successful practices for receiving timely and modern care both in the global context and at the national level. The open scientific and practical meeting will be held in an online TV format on may 26, 2020. The live broadcast will be broadcast on the official website of the pharmaceutical Race (, as well as on the online platforms of all information partners of a large-scale event.

"Takeda's research activities are aimed at developing innovative drugs in such therapeutic areas as the treatment of rare diseases, gastroenterology, immunology, neurology, Oncology and Hematology. The company aims to increase the availability of innovative therapies and new treatment methods for Russian patients and has localized the production of some of the drugs at its plant in Yaroslavl and at the production sites of its partners. We conduct a large number of international studies with the participation of leading medical centers in Russia and strive to make our contribution to the development of rare disease medicine. Holding specialized events such as "Pharmprobeg" promotes the exchange of experience among leading industry specialists, as well as the search for solutions to increase the availability of innovative therapy for patients," said Elena Kartasheva, President of Takeda Russia.

"At this difficult time for everyone, when the attention of the entire health system is focused on the serious challenge of stopping the spread of coronavirus infection, it is important not to forget about other categories of patients who are in urgent need of therapy. That is why we consider it necessary to hold open meetings with experts on the stated topic and inform the public that serious work is also being done in this direction," commented Anna Plesovskikh, General Director of the inter - industry Association "Farmprobeg".

About the company "Takeda»
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global value-driven biopharmaceutical company with a focus on research and development. The company with its head office in Japan occupies a leading position in the pharmaceutical market of the world. Takeda strives to take care of the health and future of patients by using the latest scientific advances to create innovative medicines. The company's research activities are aimed at developing new drugs in a number of therapeutic areas: Oncology, gastroenterology, neurology and the treatment of rare diseases.targeted investments are also made in the development of vaccines and blood plasma products. The company focuses on the development of innovative medicines that help change the lives of patients. We create advanced therapies on the company's combined research and development platform, forming a promising portfolio of products in several therapeutic areas. Our employees, who work in more than 80 countries and regions of the world, are dedicated to improving the quality of life of patients. For more information visit our website

The all-RUSSIAN pharmaceutical RACE is an annual automotive press tour aimed at drawing public attention to the most important issues of national goals in the field of health and related industries, as well as developing and supporting the entire chain: from regulators, manufacturers, distributors and the pharmacy segment to medical communities and patient organizations. Due to the unfavorable epidemiological situation due to the outbreak of coronavirus infection (COVID-19), in order to prevent its spread on the territory of the Russian Federation, Farmprobeg 2020 will be held in online TV mode.